Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | PRKCA | P17252 | 2/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29133986 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL17003748 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL611849 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL1340807 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL9503022 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL136431 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL9055250 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL1066768 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL440983 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL29061395 | 1.00 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2019 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094940-A | Ionizable lipids and uses thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122094957-A | Ionizable lipids and uses thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122071427-A | Amino lipid, preparation method and application thereof | 中山大学孙逸仙纪念医院 | 2026-05-22 | — | — | CN | claimed |
| WO-2026104762-A1 | NUCLEIC ACID VACCINE AGAINST TUBERCULOSIS | TAMPERE UNIVERSITY FOUNDATION SR (FI) | 2026-05-21 | — | — | WO | claimed |
| US-20260137803-A1 | LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF | GENZYME CORP (US) | 2026-05-21 | — | — | US | claimed |
| CN-122057045-A | Nanoparticle penetrating cornea and preparation method and application thereof | 良渚实验室 | 2026-05-19 | — | — | CN | claimed |
| CN-122055374-A | Lipid compounds and compositions for tissue-specific delivery of active substances | 韩国生命工学研究院 | 2026-05-15 | — | — | CN | claimed |
| US-12622979-B2 | Lipid nanoparticle used for delivering nucleic acid to brain tissue | NOF CORPORATION (JP) | 2026-05-12 | — | — | US | claimed |
| US-20260125681-A1 | DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF | HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD. (CN) | 2026-05-07 | — | — | US | claimed |
| US-20260124295-A1 | USE OF LIPID NANOPARTICLES AND IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER | UNIV FLORIDA (US) | 2026-05-07 | — | — | US | claimed |
| EP-2545900-B1 | Sun screen compounds with high sun block factor and pleasant feel | HENKEL AG & CO KGAA (DE) | 2018-08-08 | — | — | EP | claimed |
| WO-2015138423-A9 | PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME | INSMED INCORPORATED (US) | 2015-11-12 | — | — | WO | claimed |
| EP-2925303-A1 | PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME | Insmed Incorporated (US) | 2015-10-07 | — | — | EP | claimed |
| WO-2015138423-A1 | PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME | INSMED INCORPORATED (US) | 2015-09-17 | — | — | WO | claimed |
| WO-2014085813-A1 | PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME | INSMED INCORPORATED (US) | 2014-06-05 | — | — | WO | claimed |
| EP-2545900-A2 | Sun screen compounds with high sun block factor and pleasant feel | Henkel AG & Co. KGaA (DE) | 2013-01-16 | — | — | EP | claimed |
| US-7045525-B1 | Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases | NOVARTIS AG (CH) | 2006-05-16 | — | — | US | claimed |
| US-6897196-B1 | pH sensitive lipids based on ortho ester linkers, composition and method | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-05-24 | — | — | US | claimed |
| EP-0822817-B1 | USE OF (R)-PENCICLOVIR TRIPHOSPHATE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF VIRAL DISEASES | NOVARTIS INT PHARM LTD (BM) | 2003-07-23 | — | — | EP | claimed |
| US-5965158-A | Liposomal-polyene preliposomal powder and method for its preparation | THE UNIVERSITY OF TEXAS SYSTEM & BOARD OF REGENTS (US) | 1999-10-12 | — | — | US | claimed |